Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA

• Autor(a) principal: Ulbrich, Axel Gustavo
• Data de Publicação: 2001
• Outros Autores: Florido, Marlene Pereira Carvalho, Nudelman, Victor [UNIFESP], Reis, Edmara da Silva, Baracho, Gisele Vanessa, Isaac, Lourdes
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1046/j.1365-3083.2001.00934.x; http://repositorio.unifesp.br/handle/11600/26559

An 8-year-old son (L.A.S.) of consanguineous parents, presented recurrent bacterial infections, vasculitis and extremely low levels of serum C3 (0.15 mug/ml). the classical and alternative pathway haemolytic activities and the generation of opsonins and chemotactic factors derived from the activation of the complement system were markedly affected in the proband's serum. An in vitro addition of purified C3 restored the classical pathway-dependent haemolytic activity of his serum. Autoradiographs of the proband's lipopolysaccharide (LPS)-stimulated and S-35-labelled fibroblast supernatants after that the SDS-PAGE revealed no C3 alpha or beta chains. the amount of C3 mRNA synthesized by the proband's fibroblasts, as evaluated by reverse transcription-polymerase chain reaction (RT-PCR) assays, was greatly reduced.